$OKLO

Bealmear Richard Craig sold $637K of OKLO

Bealmear Richard Craig (Chief Financial Officer) sold 16,430 shares of Oklo Inc. (OKLO) at $38.76 ($0.64M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bealmear Richard Craig
Published Sep 3, 2026, 8:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Bearish
medium confidence
Mentioned
$OKLO
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLOBearishLow
01

Why it matters

The disclosed sale adds modest selling pressure but is unlikely to materially shift valuation.

02

Market read

Primary source filing; small‑scale insider sale with limited trading relevance.

03

What to watch

CFO may be diversifying holdings; no change in control or strategy indicated.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑01

Background

SEC Form 4 filing discloses an insider transaction by Oklo's CFO under a pre‑arranged 10b5‑1 plan.

Company-level read

Ticker impact

$OKLOBearishMedium confidence
Context

CFO Bealmear Richard Craig sold 16,430 shares for $636,826.80 via a 10b5‑1 plan on 2026‑09‑01.

Expected impact

Potential short‑term dip of 1‑2% as market digests the sale.

Evidence & confidence

Sale size is modest relative to holdings but involves a senior officer; market typically reacts negatively to insider sell‑offs.

Market effects

Limited; nuclear‑energy sector unlikely to be affected by a single insider sale.

None; the filing is company‑specific.

None

Counterpoint

The sale could be a routine liquidity event unrelated to company fundamentals.

Key entities

  • Oklo Inc.

    U.S. listed nuclear‑energy firm (ticker OKLO).

  • Bealmear Richard Craig

    Chief Financial Officer of Oklo.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.